FT News Briefing Tech Tonic: Defying death
Dec 22, 2025
David Gems, a researcher at University College London, sheds light on the intriguing world of ageing. He discusses the pivotal role of C. elegans in ageing research and critiques the decline of oxidative damage theory. Gems highlights how longevity treatments have transitioned from elite circles to mainstream wellness trends, underlining practical anti-ageing measures like dental care and vaccines. With insights into Silicon Valley's biohacking culture, he raises questions about the future of longevity and the importance of ongoing fundamental research.
AI Snips
Chapters
Transcript
Episode notes
IV Drip Experience In London Clinic
- Michael Peel describes receiving a wellness IV drip at a London clinic that delivered vitamins and antioxidants directly into his bloodstream.
- The treatment illustrates how longevity practices have moved from elite secrecy to mainstream consumer clinics.
Oxidative Damage Is A Symptom Not The Cause
- David Gems explains that the oxidative damage theory of ageing was once dominant but lost support after antioxidant interventions failed to extend lifespan in lab models.
- He concludes oxidative damage is mostly a consequence of ageing rather than its root cause.
Funding Outpaced Scientific Understanding
- Large sums of investor money have flowed into longevity despite limited scientific consensus on ageing mechanisms, creating hype-heavy conferences and inflated promises.
- David Gems warns that funding has outpaced real scientific progress in understanding ageing.